AzTrials
AzTrials

ChildPeDiaNCT04882553

Pediatric Diaphragm Thickness Trial

A study testing Diaphragmatic echography, Measurement of esophageal pressure and Registration of respiratory mechanics in people with Child, run by University Hospital, Antwerp at 1 site in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The evaluation of diaphragm function in ventilated patients is not easy. One option is to use esophageal pressure (Pes) measurements but recently, diaphragmatic ultrasound has proven itself as a useful tool in this setting. Read more about this study

Who is it for?
Ages 28 days to 13 years
Conditions the study is for
Child
What is being tested?
Diaphragmatic echography, Measurement of esophageal pressure and Registration of respiratory mechanics
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteBelgium
Study dates
11 Jun 2021to 30 Nov 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 28 days to 13 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

None listed.

Who cannot join

  • The patient is mechanically ventilated before start of the study.
  • The patient is not anticipated to breathe spontaneously for a substantial amount of time prior to emergence from anesthesia
  • The patient is known or suspected to have an anatomical malformation or surgical correction of the diaphragm.
  • The patient suffers from a disease that may impair diaphragmatic function:
  • Central neural disease at the level of the brain (Stroke, Arnold-Chiari malformation) and spinal cord (quadriplegia, spinal muscular atrophy, syringomyelia).
  • Neural disease of the phrenic nerve (Guillain-Barré syndrome, tumor compression).
  • Disorders of the neuromuscular junction.
  • Muscular diseases (muscular dystrophies, myositis (infectious, inflammatory, metabolic).

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • University Hospital Antwerp

    Edegem, Antwerp, 2650

Other trials in Belgium

About this study

Official title: The Relation Between Oesophageal Pressure and Diaphragm Thickening Fraction in Spontaneously Breathing Sedated Children: a Feasibility Study.

The evaluation of diaphragm function in ventilated patients is not easy. One option is to use esophageal pressure (Pes) measurements but recently, diaphragmatic ultrasound has proven itself as a useful tool in this setting. In adults the thickening fraction (TF), which describes the difference in thickness between end-inspiration and end-expiration, correlates with the diaphragmatic pressure-time product per breath (PTPdi), an esophageal pressure-derived work of breathing parameter. There is a lack of data that tells us whether the same is true in children. This physiological study intends to look at the correlation between esophageal pressures and thickening fraction assessed by ultrasound in a pediatric cohort of patients.

Read the detailed description

The gold standard in evaluating lung mechanics is the esophageal pressure. And although diaphragm ultrasound has been reported to be feasible in assessing diaphragm activity in sedated patients, no study has thus far looked at the relationship between the ultrasound parameters (i.e. thickening fraction) and the esophageal pressure. This is a single-centre physiological cohort study to evaluate the feasibility of using the thickening fraction as a parameter for diaphragm activity during spontaneous breathing in sedated children. Data will be collected during an elective surgical procedure with a patient under general anesthesia. If the patient's legal representative provides written informed consent, the patient is enrolled in the study before start of the anesthetic procedure and the trial ends on the moment of removal of the laryngeal mask.The registration of the physiological data will not interfere with the surgery.The thickening fraction (using ultrasound) and pressure measurements will be performed simultaneously and repetitive during different loads on the respiratory system.Esophageal pressures (Pes) will be measured with a single air-filled balloon catheter(AVEA™ smarthcath pediatric 7 Fr, Vyaire Medical Inc., IL, USA). The balloon catheter will be inserted nasally after the induction of anesthesia. The catheter will then be connected to a pressure transducer (FluxMed, MBMED, Argentina). The appropriate placement will be checked by commonly used methods. Firstly, the appropriate depth of insertion will be estimated by measuring the nose-ear-xyphoid distance, which is the distance from the nose to the diaphragm. Secondly, the balloon catheter will be inserted more deeply than this predicted distance, placing it in the stomach, and a positive pressure swing when mild abdominal pressure is exerted on a slightly inflated balloon will be noted. Thirdly, when retracted into the esophagus, cardiac reflections on the pressure monitor will appear. Fourth, when applying positive pressure ventilation, we will look for a positive deflection on the pressure curve. The output from the pressure transducer will be saved from the Fluxmed respiratory mechanics monitor. Pes will be measured over at least five consecutive breaths selected at the end of the pressure recordings. Ultrasound recordings will be done with the BK 3500 ultrasound machine, using a linear high-resolution probe. The parameter measured is the distance between the pleura and peritoneum as seen on a 2D image. The thickness using B-mode ultrasound imaging at end expiration on 10cm H2O of positive end-expiratory pressure (PEEP) and on zero PEEP (ZEEP) will be assessed. Furthermore, the thickness with Mmode imaging, both at end-inspiration (TEI) and end-expiration (TEE) will be measured. A transducer will be placed on the right side of the body in the midaxillary line at the level of the 8th and 9th intercostal space, the so-called zone of apposition. The probe will be positioned perpendicular to the skin, and temporary markings will be applied to the skin. Subjects are positioned in a supine position. TEE will be measured just before the thickening start and TEI measured at maximal thickening. Measurements will be averaged out of three or more consecutive breaths. The thickening fraction (TF) is calculated as (TEI - TEE)/TEE and expressed as a percentage. Digital images will be stored and re-interpreted by a separate, blinded interpreter.The thickening fraction recordings will be repeated during different loads on the respiratory system, with varying the depth of anesthesia (mean alveolar concentration of anesthetic vapor - MAC) and different added respiratory loads with a threshold valve and different levels of PEEP. An anesthesia circle circuit with standard pediatric tubing will consistently be used. The lowest dose of opioids will be used to the extent clinically possible.

Condition #1: during positive pressure ventilation, no spontaneous breaths Condition #2: spontaneous, MAC 1.5, PEEP, no added respiratory load Condition #3: spontaneous, MAC 1.5, PEEP 10, no added respiratory load (only Tdi, no TF) Condition #4: spontaneous, MAC 1.5, ZEEP, no extra added respiratory load Condition #5: spontaneous, MAC 1, ZEEP, no added respiratory load Condition #6: spontaneous, MAC 1, ZEEP, 7 cm H2O added respiratory load Condition #7: spontaneous, MAC 1, ZEEP, 15 cm H2O added respiratory load

These different conditions will alter the work of breathing the diaphragm has to perform and will allow us to better correlate thickening fraction with esophageal pressure.Preceding this study, a reproducibility study will assess intra-observer reproducibility for the researcher doing the ultrasound measurements.

A power analysis is not possible, as this is the first study comparing these parameters in children. Data will be analyzed using the SPSS statistical software package (SPSS Inc., IL, USA). Continuous variables will be reported as median (interquartile range). Friedman test and Wilcoxon paired tests (with post hoc Bonferonni correction) will be used to assess differences between related variables. Correlations between TF and Pes will be calculated using the Spearman method and performed for the entire data set (including all four respiratory conditions of each patient) because of the limited sample size. Two-tailed p values less than 0.05 will be considered significant.

All precautions will be taken to prevent complications due to placement of the balloon catheter but nevertheless all adverse events will be assessed.

Conditions
Child
Being tested
Diaphragmatic echography, Measurement of esophageal pressure, Registration of respiratory mechanics
Keywords
diaphragm thickening fraction, oesophageal pressure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Diaphragmatic echographyProcedure or surgery

    Echography of the diaphragm at the zone of apposition. End-inspiratory and/or end-expiratory thickness of the diaphragm will be measured in M-mode.

  • Measurement of esophageal pressureProcedure or surgery

    Pressure will be measured in the lower third of the esophagus using an esophageal balloon and pressure transducer.

  • Registration of respiratory mechanicsDiagnostic test

    Pressures and volumes will be registered by the Fluxmed respiratory monitor (MBMED, Argentina)

Study groups in NCT04882553
Study groupRoleWhat they receive
Incremental inspiratory effortExperimentalEvery participant will be subjected to a stepwise incremental inspiratory effort: 1. Ventilated 2. Baseline spontaneous breathing with deep anesthesia (minimal alveolar concentration 1.5) 3. Spontaneous breathing with PEEP 10 and deep anesthesia (minimal alveolar concentration 1.5) 4. Spontaneous breathing with PEEP 0 and deep anesthesia (minimal alveolar concentration 1.5) 5. Spontaneous breathing with PEEP 0 and moderate anesthesia (minimal alveolar concentration 1.0) 6. Spontaneous breathing with PEEP 0 and moderate anesthesia (minimal alveolar concentration 1.0) and added inspiratory threshold of +7cmH2O 7. Spontaneous breathing with PEEP 0 and moderate anesthesia (minimal alveolar concentration 1.0) and added inspiratory threshold of +15cmH2O
Receives: Procedure: Diaphragmatic echography; Procedure: Measurement of esophageal pressure; Diagnostic Test: Registration of respiratory mechanics

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Esophageal pressure (cmH2O) at increasing levels of respiratory effort in spontaneously breathing, sedated children.

    Esophageal pressures are measured in the lower third of the esophagus using an esophageal balloon and registered by an external pressure transducer.

    Measured: Perioperatively

  2. Diaphragmatic thickening fraction (%) at increasing levels of respiratory effort in spontaneously breathing, sedated children.

    The diaphragmatic thickening fraction (%) is calculated as [thickness at end-inspiration (mm) - thickness at end-expiration (mm)] / thickness at end-expiration (mm) x 100%.

    Diaphragmatic thickness is measured by ultrasound.

    Measured: Perioperatively

  3. Feasibility (% success) of measuring diaphragmatic thickening fraction in spontaneously breathing ventilated children

    The rate of success of diaphragmatic ultrasound in children, calculated as count of successful measurements / [count of successful measurements + count of unsuccessful measurements] x 100%

    Measured: Perioperatively

Secondary outcomes (1)
  1. Diaphragm thickness (mm) at different levels of positive end-expiratory pressure in spontaneously breathing, sedated children.

    Diaphragmatic thickness is measured by ultrasound.

    Measured: Perioperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 May 2021
  2. Study start11 Jun 2021
  3. Primary completion30 Nov 2021
  4. Study completion30 Nov 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Model description
a single-centre physiological cohort study to evaluate the feasibility of using the thickening fraction as a parameter for diaphragm activity during spontaneous breathing in sedated children.
Masking
None (open label)
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04882553
Sponsor's protocol ID
21/15/208
Other IDs
1653, 21/15/208
Acronym
PeDia
Status last verified
Sep 2021
First submitted
6 May 2021
Last updated
24 Jan 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • De Meyer GR, Flamey L, Adriaensens I, Van der Aerschot M, Van de Walle H, Vanmarsenille I, Jorens PG, Goligher EC, Saldien V, Schepens T. The Relationship Between Esophageal Pressure and Diaphragm Thickening Fraction in Spontaneously Breathing Sedated Children: A Feasibility Study. Pediatr Crit Care Med. 2023 Aug 1;24(8):652-661. doi: 10.1097/PCC.0000000000003248. Epub 2023 Apr 24.

    PubMed 37092829

Questions about this trial

What is this clinical trial studying?

A study testing Diaphragmatic echography, Measurement of esophageal pressure and Registration of respiratory mechanics in people with Child, run by University Hospital, Antwerp at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Esophageal pressure (cmH2O) at increasing levels of respiratory effort in spontaneously breathing, sedated children. (time frame: Perioperatively). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04882553, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in